Yeast prions: Structure, biology, and prion-handling systems

Microbiology and Molecular Biology Reviews

Volumn 79, Issue 1, 2015, Pages 1-17

  Wickner, Reed B ^a   Shewmaker, Frank P ^b   Bateman, David A ^a   Edskes, Herman K ^a   Gorkovskiy, Anton ^a   Dayani, Yaron ^a   Bezsonov, Evgeny E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 104; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; PRION PROTEIN; AMINO ACID TRANSPORTER; AMYLOID; BTN2 PROTEIN, S CEREVISIAE; CUR1 PROTEIN, S CEREVISIAE; PRION; SACCHAROMYCES CEREVISIAE PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FUNGAL GENETICS; FUNGUS TRANSMISSION; GENE MUTATION; HETEROKARYON; HISTORY OF MEDICINE; HUMAN; HUNTINGTON CHOREA; MOLECULAR MIMICRY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PODOSPORA ANSERINA; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SEED PRODUCTION; YEAST; ANIMAL; CHEMISTRY; FUNGUS; GENETICS; METABOLISM; PHYSIOLOGY; PRION; PROTEIN CONFORMATION; SACCHAROMYCES CEREVISIAE;

FUNGAL PRION; MAMMALIA;

AMINO ACID TRANSPORT SYSTEMS; AMYLOID; ANIMALS; FUNGI; HUMANS; MOLECULAR CHAPERONES; PRIONS; PROTEIN CONFORMATION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; YEASTS;

EID: 84925258216     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00041-14     Document Type: Review

References (217)

1. Alper T, Haig DA, Clarke MC. 1966. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22: 278-284. http://dx.doi.org/10.1016/0006-291X(66)90478-5.
2. Griffith JS. 1967. Self-replication and scrapie. Nature 215: 1043-1044. http://dx.doi.org/10.1038/2151043a0.
3. Wickner RB. 1994. [URE3] as an altered URE2 protein: Evidence for a prion analog in S. cerevisiae. Science 264: 566-569. http://dx.doi.org/10.1126/science.7909170.
4. Baxa U, Wickner RB, Steven AC, Anderson D, Marekov L, Yau W-M, Tycko R. 2007. Characterization of β-sheet structure in Ure2p1-89 yeast prion fibrils by solid state nuclear magnetic resonance. Biochemistry 46: 13149-13162. http://dx.doi.org/10.1021/bi700826b.
5. Shewmaker F, Wickner RB, Tycko R. 2006. Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure. Proc Natl Acad Sci U S A 103: 19754-19759. http://dx.doi.org/10.1073/pnas.0609638103.
6. +] prion, has a parallel in-register β-sheet structure. Proc Natl Acad Sci U S A 105: 2403-2408. http://dx.doi.org/10.1073/pnas.0712032105.
7. Wickner RB, Edskes HK, Bateman DA, Kelly AC, Gorkovskiy A, Dayani Y, Zhou A. 2013. Amyloids and yeast prion biology. Biochemistry 52: 1514-1527. http://dx.doi.org/10.1021/bi301686a.
8. Kraus A, Groveman BR, Caughey B. 2013. Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol 67: 543-564. http://dx.doi.org/10.1146/annurev-micro-092412-155735.
9. Lloyd S, Mead S, Collinge J. 2013. Genetics of prion diseases. Curr Opin Genet Dev 23: 345-351. http://dx.doi.org/10.1016/j.gde.2013.02.012.
10. Bueler H, Aguzzi A, Sailer A, Greiner R-A, Autenried P, Aguet M, Weissmann C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347. http://dx.doi.org/10.1016/0092-8674(93)90360-3.
11. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C, Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ. 1990. Transgenic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673-686. http://dx.doi.org/10.1016/0092-8674(90)90134-Z.
12. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. 2012. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 109: 8546-8551. http://dx.doi.org/10.1073/pnas.1204498109.
13. McGlinchey R, Kryndushkin D, Wickner RB. 2011. Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci U S A 108: 5337-5341. http://dx.doi.org/10.1073/pnas.1102762108.
14. Cox BS. 1965. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20: 505-521. http://dx.doi.org/10.1038/hdy.1965.65.
15. Lacroute F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 106: 519-522.
16. Coustou V, Deleu C, Saupe S, Begueret J. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci U S A 94: 9773-9778. http://dx.doi.org/10.1073/pnas.94.18.9773.
17. Wickner RB. 1997. A new prion controls fungal cell fusion incompatibility. Proc Natl Acad Sci U S A 94: 10012-10014. http://dx.doi.org/10.1073/pnas.94.19.10012.
18. Saupe SJ. 2011. The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Sem Cell Dev Biol 22: 460-468. http://dx.doi.org/10.1016/j.semcdb.2011.02.019.
19. Eaglestone SS, Cox BS, Tuite MF. 1999. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 18: 1974-1981. http://dx.doi.org/10.1093/emboj/18.7.1974.
20. True HL, Lindquist SL. 2000. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407: 477-483. http://dx.doi.org/10.1038/35035005.
21. Aguzzi A, Falsig J. 2012. Prion propagation, toxicity and degradation. Nat Neurosci 15: 936-939. http://dx.doi.org/10.1038/nn.3120.
22. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM-Y. 2012. Pathological-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice. Science 338: 949-953. http://dx.doi.org/10.1126/science.1227157.
23. Jucker M, Walker LC. 2011. Pathogenic protein seeding in Alzheimer's disease and other neurodegenerative disorders. Ann Neurol 70: 532-540. http://dx.doi.org/10.1002/ana.22615.
24. Aigle M, Lacroute F. 1975. Genetical aspects of [URE3], a non-Mendelian, cytoplasmically inherited mutation in yeast. Mol Gen Genet 136: 327-335. http://dx.doi.org/10.1007/BF00341717.
25. Singh AC, Helms C, Sherman F. 1979. Mutation of the non-Mendelian suppressor y in yeast by hypertonic media. Proc Natl Acad Sci U S A 76: 1952-1956. http://dx.doi.org/10.1073/pnas.76.4.1952.
26. Lund PM, Cox BS. 1981. Reversion analysis of [psi-] mutations in Saccharomyces cerevisiae. Genet Res 37: 173-182. http://dx.doi.org/10.1017/S0016672300020140.
27. Chernoff YO, Derkach IL, Inge-Vechtomov SG. 1993. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr Genet 24: 268-270. http://dx.doi.org/10.1007/BF00351802.
28. Masison DC, Wickner RB. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270: 93-95. http://dx.doi.org/10.1126/science.270.5233.93.
29. Masison DC, Maddelein M-L, Wickner RB. 1997. The prion model for [URE3] of yeast: Spontaneous generation and requirements for propagation. Proc Natl Acad Sci U S A 94: 12503-12508. http://dx.doi.org/10.1073/pnas.94.23.12503.
30. Cooper TG. 2002. Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to the GATA factors: Connecting the dots. FEMS Microbiol Rev 26: 223-238. http://dx.doi.org/10.1111/j.1574-6976.2002.tb00612.x.
31. Magasanik B, Kaiser CA. 2002. Nitrogen regulation in Saccharomyces cerevisiae. Gene 290: 1-18. http://dx.doi.org/10.1016/S0378-1119(02)00 558-9.
32. Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB. 2007. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae. Genetics 176: 1557-1565. http://dx.doi.org/10.1534/genetics.107.074153.
33. Frolova L, Le Goff X, Zhouravleva G, Davydova E, Philippe M, Kisselev L. 1996. Eukaryotic polypeptide chain release factor eRF3 is an eRF1-And ribosome-dependent guanosine triphosphatase. RNA 2: 334-341.
34. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, Nierras CR, Cox BS, Ter-Avanesyan MD, Tuite MF. 1995. The products of the SUP45 eRF1. and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14: 4365-4373.
35. TerAvanesyan A, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. 1994. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi-] in the yeast Saccharomyces cerevisiae. Genetics 137: 671-676.
36. Cosson B, Couturier A, Chabelskaya S, Kiktev D, Inge-Vechtomov S, Philippe M, Zhouravleva G. 2002. Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI+] propagation. Mol Cell Biol 22: 3301-3315. http://dx.doi.org/10.1128/MCB.22.10.3301-3315.2002.
37. Funakoshi Y, Doi Y, Hosoda N, Uchida N, Osawa M, Shimada I, Tsujimoto M, Suzuki T, Katada T, Hoshino S. 2007. Mechanism of mRNA deadenylation: Evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases. Genes Dev 21: 3135-3148. http://dx.doi.org/10.1101/gad.1597707.
38. Hoshino S, Imai M, Kobayashi T, Uchida N, Katada T. 1999. The eukaryotic polypeptide chain releasing factor eRF3/GSPT. carrying the translation termination signal to the 3=-poly(A. tail of mRNA. J Biol Chem 274: 16677-16680. http://dx.doi.org/10.1074/jbc.274.24.16677.
39. Hosoda N, Kobayashii T, Uchida N, Funakoshi Y, Kikuchi Y, Hoshino S, Katada T. 2003. Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J Biol Chem 278: 38287-38291. http://dx.doi.org/10.1074/jbc.C300300200.
40. Kobayashi T, Funakoshi Y, Hoshino S, Katada T. 2004. The GTPbinding release factor eRF3 as a key mediator coupling translation termination to mRNA decay. J Biol Chem 279: 45693-45700. http://dx.doi.org/10.1074/jbc.M405163200.
41. Li X, Rayman JB, Kandel ER, Derkatch IL. 2014. Functional role of Tia1/Pub1 and Sup35 prion domains: Directing protein synthesis machinery to the tubulin cytoskeleton. Mol Cell 55: 305-318. http://dx.doi.org/10.1016/j.molcel.2014.05.027.
42. Chang H-Y, Lin J-Y, Lee H-C, Wang H-L, King C-Y. 2008. Strainspecific sequences required for yeast prion [PSI+] propagation. Proc Natl Acad Sci U S A 105: 13345-13350. http://dx.doi.org/10.1073/pnas.0802215105.
43. King CY, Diaz-Avalos R. 2004. Protein-only transmission of three yeast prion strains. Nature 428: 319-323. http://dx.doi.org/10.1038/nature02391.
44. Bradley ME, Liebman SW. 2004. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions. Mol Microbiol 51: 1649-1659. http://dx.doi.org/10.1111/j.1365-2958.2003.03955.x.
45. Liu J-J, Sondheimer N, Lindquist S. 2002. Changes in the middle region of Sup35p profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci U S A 99: 16446-16453. http://dx.doi.org/10.1073/pnas.252652099.
46. Bateman DA, Wickner RB. 2012. [PSI+] prion transmission barriers protect Saccharomyces cerevisiae from infection: Intraspecies 'species barriers'.Genetics 190: 569-579. http://dx.doi.org/10.1534/genetics.111.136655.
47. Shewmaker F, Kryndushkin D, Chen B, Tycko R, Wickner RB. 2009. Two prion variants of Sup35p have in-register β-sheet structures, independent of hydration. Biochemistry 48: 5074-5082. http://dx.doi.org/10.1021/bi900345q.
48. Toyama BH, Kelly MJ, Gross JD, Weissman JS. 2007. The structural basis of yeast prion strain variants. Nature 449: 233-237. http://dx.doi.org/10.1038/nature06108.
49. Patino MM, Liu J-J, Glover JR, Lindquist S. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273: 622-626. http://dx.doi.org/10.1126/science.273.5275.622.
50. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. 1996. Propagation of the yeast prion-like [psi-] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15: 3127-3134.
51. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. 1997. In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277: 381-383. http://dx.doi.org/10.1126/science.277.5324.381.
52. King C-Y, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K. 1997. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci U S A 94: 6618-6622. http://dx.doi.org/10.1073/pnas.94.13.6618.
53. Glover JR, Kowal AS, Shirmer EC, Patino MM, Liu J-J, Lindquist S. 1997. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89: 811-819. http://dx.doi.org/10.1016/S0092-8674(00)80264-0.
54. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428: 323-328. http://dx.doi.org/10.1038/nature02392.
55. Edskes HK, Gray VT, Wickner RB. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci U S A 96: 1498-1503. http://dx.doi.org/10.1073/pnas.96.4.1498.
56. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283: 1339-1343. http://dx.doi.org/10.1126/science.283.5406.1339.
57. Brachmann A, Baxa U, Wickner RB. 2005. Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 24: 3082-3092. http://dx.doi.org/10.1038/sj.emboj.7600772.
58. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW. 1997. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147: 507-519.
59. Sondheimer N, Lindquist S. 2000. Rnq1: An epigenetic modifier of protein function in yeast. Mol Cell 5: 163-172. http://dx.doi.org/10.1016/S1097-2765(00)80412-8.
60. Derkatch IL, Bradley ME, Hong JY, Liebman SW. 2001. Prions affect the appearance of other prions: The story of [PIN]. Cell 106: 171-182. http://dx.doi.org/10.1016/S0092-8674(01)00427-5.
61. Du Z, Park K-W, Yu H, Fan Q, Li L. 2008. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat Genet 40: 460-465. http://dx.doi.org/10.1038/ng.112.
62. Patel BK, Gavin-Smyth J, Liebman SW. 2009. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat Cell Biol 11: 344-349. http://dx.doi.org/10.1038/ncb1843.
63. Suzuki G, Shimazu N, Tanaka M. 2012. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 336: 355-359. http://dx.doi.org/10.1126/science.1219491.
64. Alberti S, Halfmann R, King O, Kapila A, Lindquist S. 2009. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137: 146-158. http://dx.doi.org/10.1016/j.cell.2009.02.044.
65. Rogoza T, Goginashvili A, Rodionova S, Ivanov M, Viktorovskaya O, Rubel A, Volkov K, Mironova L. 2010. Non-mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1. Proc Natl Acad Sci U S A 107: 10573-10577. http://dx.doi.org/10.1073/pnas.1005949107.
66. Radchenko E, Rogoza RE, Khokhrina M, Drozdova P, Mironova L. 2011. SUP35 expression is enhanced in yeast containing [ISP+], a prion form of the transcription regulator Sfp1. Prion 5: 317-322. http://dx.doi.org/10.4161/pri.18426.
67. Jones EW. 1991. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J Biol Chem 266: 7963-7966.
68. Roberts BT, Wickner RB. 2003. A class of prions that propagate via covalent auto-Activation. Genes Dev 17: 2083-2087. http://dx.doi.org/10.1101/gad.1115803.
69. Ball AJ, Wong DK, Elliott JJ. 1976. Glucosamine resistance in yeast. I. A preliminary genetic analysis. Genetics 84: 311-317.
70. Kunz BA, Ball AJ. 1977. Glucosamine resistance in yeast. II. Cytoplasmic determinants conferring resistance. Mol Gen Genet 153: 169-177.
71. Brown JC, Lindquist S. 2009. A heritable switch in carbon source utilization driven by an unusual yeast prion. Genes Dev 23: 2320-2332. http://dx.doi.org/10.1101/gad.1839109.
72. Glass NL, Dementhon K. 2006. Non-self recognition and programmed cell death in filamentous fungi. Curr Opin Microbiol 9: 553-558. http://dx.doi.org/10.1016/j.mib.2006.09.001.
73. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. 2002. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci U S A 99: 7402-7407. http://dx.doi.org/10.1073/pnas.072199199.
74. Cuille J, Chelle PL. 1939. Experimental transmission of trembling to the goat. C R Seances Acad Sci 208: 1058-1060.
75. Priola SA, Caughey B, Race RE, Chesebro B. 1994. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68: 4873-4878.
76. Baudin-Baillieu A, Fernandez-Bellot E, Reine F, Coissac E, Cullin C. 2003. Conservation of the prion properties of Ure2p through evolution. Mol Biol Cell 14: 3449-3458. http://dx.doi.org/10.1091/mbc.E03-01-0007.
77. Chen B, Newnam GP, Chernoff YO. 2007. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc Natl Acad Sci USA104: 2791-2796. http://dx.doi.org/10.1073/pnas.0611158104.
78. Chernoff YO, Galkin AP, Lewitin E, Chernova TA, Newnam GP, Belenkiy SM. 2000. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein. Mol Microbiol 35: 865-876. http://dx.doi.org/10.1046/j.1365-2958.2000.01761.x.
79. Edskes HK, Wickner RB. 2002. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein. Proc Natl Acad Sci USA99(Suppl 4): 16384-16391. http://dx.doi.org/10.1073/pnas.162349599.
80. Kushnirov VV, Kochneva-Pervukhova NV, Cechenova MB, Frolova NS, Ter-Avanesyan MD. 2000. Prion properties of the Sup35 protein of yeast Pichia methanolica.EMBOJ 19: 324-331. http://dx.doi.org/10.1093/emboj/19.3.324.
81. Santoso A, Chien P, Osherovich LZ, Weissman JS. 2000. Molecular basis of a yeast prion species barrier. Cell 100: 277-288. http://dx.doi.org/10.1016/S0092-8674(00)81565-2.
82. Conde J, Fink GR. 1976. A mutant of Saccharomyces cerevisiae defective for nuclear fusion. Proc Natl Acad Sci U S A 73: 3651-3655. http://dx.doi.org/10.1073/pnas.73.10.3651.
83. Edskes HK, McCann LM, Hebert AM, Wickner RB. 2009. Prion variants and species barriers among Saccharomyces Ure2 proteins. Genetics 181: 1159-1167. http://dx.doi.org/10.1534/genetics.108.099929.
84. Resende CG, Outeiro TF, Sands L, Lindquist S, Tuite MF. 2003. Prion protein gene polymorphisms in Saccharomyces cerevisiae. Mol Microbiol 49: 1005-1017. http://dx.doi.org/10.1046/j.1365-2958.2003.03608.x.
85. Kelly AC, Shewmaker FP, Kryndushkin D, Wickner RB. 2012. Sex, prions and plasmids in yeast. Proc Natl Acad Sci USA109: E2683-E2690. http://dx.doi.org/10.1073/pnas.1213449109.
86. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J. 2003. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300: 640-643. http://dx.doi.org/10.1126/science.1083320.
87. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. 1996. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144: 1375-1386.
88. Schlumpberger M, Prusiner SB, Herskowitz I. 2001. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 21: 7035-7046. http://dx.doi.org/10.1128/MCB.21.20.7035-7046.2001.
89. Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. 2002. Interactions among prions and prion "strains" in yeast. Proc Natl Acad Sci U S A 99(Suppl 4): 16392-16399. http://dx.doi.org/10.1073/pnas.152330699.
90. +] yeast prion variants. Genetics 165: 1675-1685.
91. Borchsenius AS, Muller S, Newnam GP, Inge-Vechtomov SG, Chernoff YO. 2006. Prion variant maintained only at high levels of the Hsp104 disaggregase. Curr Genet 49: 21-29. http://dx.doi.org/10.1007/s00294-005-0035-0.
92. Kushnirov VV, Kryndushkin D, Boguta M, Smirnov VN, Ter-Avanesyan MD. 2000. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol 10: 1443-1446. http://dx.doi.org/10.1016/S0960-9822(00)00802-2.
93. +] prion conformations in Saccharomyces cerevisiae. J Biol Chem 288: 1266-1276. http://dx.doi.org/10.1074/jbc.M112.377564.
94. Vishveshwara N, Liebman SW. 2009. Heterologous cross-seeding mimics cross-species prion conversion in a yeast model. BMC Biol 7: 26. http://dx.doi.org/10.1186/1741-7007-7-26.
95. Bateman D, Wickner RB. 2013. The [PSI+] prion exists as a dynamic cloud of variants. PLoS Genet 9: E1003257. http://dx.doi.org/10.1371/journal.pgen.1003257.
96. Wickner RB, Beszonov E, Bateman DA. 2014. Normal levels of the antiprion proteins Btn2 and Cur1 cure most newly formed [URE3] prion variants. Proc Natl Acad Sci U S A 111: E2711-E2720. http://dx.doi.org/10.1073/pnas.1409582111.
97. Bessen RA, Marsh RF. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66: 2096-2101.
98. Kimberlin RH, Cole S, Walker CA. 1987. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 68: 1875-1881. http://dx.doi.org/10.1099/0022-1317-68-7-1875.
99. Collinge J, Clarke AR. 2007. A general model of prion strains and their pathogenicity. Science 318: 930-936. http://dx.doi.org/10.1126/science.1138718.
100. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. 2010. Darwinian evolution of prions in cell culture. Science 327: 869-872. http://dx.doi.org/10.1126/science.1183218.
101. Ross ED, Baxa U, Wickner RB. 2004. Scrambled prion domains form prions and amyloid. Mol Cell Biol 24: 7206-7213. http://dx.doi.org/10.1128/MCB.24.16.7206-7213.2004.
102. Ross ED, Edskes HK, Terry MJ, Wickner RB. 2005. Primary sequence independence for prion formation. Proc Natl Acad Sci U S A 102: 12825-12830. http://dx.doi.org/10.1073/pnas.0506136102.
103. Toombs JA, Liss NM, Cobble KR, Ben-Musa Z, Ross ED. 2011. [PSI] maintenance is dependent on the composition, not the primary sequence, of the oligopeptide repeat domain. PLoS One 6: E21953. http://dx.doi.org/10.1371/journal.pone.0021953.
104. Toombs JA, McCarty BR, Ross ED. 2010. Compositional determinants of prion formation in yeast. Mol Cell Biol 30: 319-332. http://dx.doi.org/10.1128/MCB.01140-09.
105. DePace AH, Santoso A, Hillner P, Weissman JS. 1998. A critical role for amino-Terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93: 1241-1252. http://dx.doi.org/10.1016/S0092-8674(00)81467-1.
106. - mutation which eliminates the [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137: 659-670.
107. Ross ED, Minton AP, Wickner RB. 2005. Prion domains: Sequences, structures and interactions. Nat Cell Biol 7: 1039-1044. http://dx.doi.org/10.1038/ncb1105-1039.
108. Tycko R. 2011. Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys Chem 62: 279-299. http://dx.doi.org/10.1146/annurev-physchem-032210-103539.
109. Tycko R, Wickner RB. 2013. Molecular structures of amyloid and prion fibrils: Consensus versus controversy. Acc Chem Res 46: 1487-1496. http://dx.doi.org/10.1021/ar300282r.
110. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH, Saupe SJ, Riek R. 2005. Correlation of structural elements and infectivity of the HET-s prion. Nature 435: 844-848. http://dx.doi.org/10.1038/nature03793.
111. Siemer AB, Ritter C, Steinmetz MO, Ernst M, Riek R, Meier BH. 2006. 13C, 15N resonance assignment of parts of the HET-s prion protein in its amyloid form. J Biomol NMR 34: 75-87. http://dx.doi.org/10.1007/s10858-005-5582-7.
112. Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, Meier BH. 2008. Amyloid fibrils of the HET-s(218-279. prion form a beta solenoid with a triangular hydrophobic core. Science 319: 1523-1526. http://dx.doi.org/10.1126/science.1151839.
113. Baxa U, Cheng N, Winkler DC, Chiu TK, Davies DR, Sharma D, Inouye H, Kirschner DA, Wickner RB, Steven AC. 2005. Filaments of the Ure2p prion protein have a cross-beta core structure. J Struct Biol 150: 170-179. http://dx.doi.org/10.1016/j.jsb.2005.02.007.
114. Frederick KK, Debelouchina GT, Kayatekin C, Dominy T, Jacvone AC, Griffin RG, Lindquist S. 2014. Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem Biol 21: 1-11. http://dx.doi.org/10.1016/j.chembiol.2013.12.010.
115. Luckgei N, Schutz AK, Bousset L, Habenstein B, Souigues Y, Gardiennet C, Meier BH, Melki R, Bockmann A. 2013. The conformation of the prion domain of Sup35p in isolation and in the full-length protein. Angew Chem Int Ed Engl 52: 12741-12744. http://dx.doi.org/10.1002/anie.201304699.
116. Kryndushkin DS, Wickner RB, Tycko R. 2011. The core of Ure2p prion fibrils is formed by the N-Terminal segment in a parallel cross structure: Evidence from solid-state NMR. J Mol Biol 409: 263-277. http://dx.doi.org/10.1016/j.jmb.2011.03.067.
117. Shewmaker F, Ross ED, Tycko R, Wickner RB. 2008. Amyloids of shuffled prion domains that form prions have a parallel in-register β-sheet structure. Biochemistry 47: 4000-4007. http://dx.doi.org/10.1021/bi7024589.
118. Ngo S, Gu L, Guo Z. 2011. Hierarchical organization in the amyloid core of yeast prion protein Ure2. J Biol Chem 286: 29691-29699. http://dx.doi.org/10.1074/jbc.M111.269092.
119. Ngo S, Chiang V, Guo Z. 2012. Quantitative analysis of spin exchange interactions to identify μ strand and turn regions in Ure2 prion domain fibrils with site-directed spin labeling. J Struct Biol 180: 374-381. http://dx.doi.org/10.1016/j.jsb.2012.08.008.
120. Gorkovskiy A, Thurber KR, Tycko R, Wickner RB. 2014. Locating the folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid. Proc Natl Acad Sci U S A 111: E4615-E4622. http://dx.doi.org/10.1073/pnas.1417974111.
121. Krishnan R, Lindquist S. 2005. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435: 765-772. http://dx.doi.org/10.1038/nature03679.
122. Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, Wickner RB, Steven A. 2003. Architecture of Ure2p prion filaments: The N-Terminal domain forms a central core fiber. J Biol Chem 278: 43717-43727. http://dx.doi.org/10.1074/jbc.M306004200.
123. Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R. 2009. Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci U S A 106: 14339-14344. http://dx.doi.org/10.1073/pnas.0907821106.
124. Diaz-Avalos R, King CY, Wall JS, Simon M, Caspar DLD. 2005. Strain-specific morphologies of yeast prion amyloids. Proc Natl Acad Sci U S A 102: 10165-10170. http://dx.doi.org/10.1073/pnas.0504599102.
125. Loquet A, Bousset L, Gardiennet C, Sourigues Y, Wasmer C, Habenstein B, Schutz A, Meier BH, Melki R. 2009. Prion fibrils of Ure2p assembled under physiological conditions contain highly ordered, natively folded molecules. J Mol Biol 394: 108-118. http://dx.doi.org/10.1016/j.jmb.2009.09.016.
126. Bai M, Zhou JM, Perrett S. 2004. The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms. J Biol Chem 279: 50025-50030. http://dx.doi.org/10.1074/jbc.M406612200.
127. Wickner RB, Shewmaker F, Kryndushkin D, Edskes HK. 2008. Protein inheritance prions. based on parallel in-register β-sheet amyloid structures. Bioessays 30: 955-964. http://dx.doi.org/10.1002/bies.20821.
128. Collins SR, Douglass A, Vale RD, Weissman JS. 2004. Mechanism of prion propagation: Amyloid growth occurs by monomer addition. PLoS Biol 2: E321. http://dx.doi.org/10.1371/journal.pbio.0020321.
129. Bernet J. 1965. Mode d'action des gènes de barrage et relation entre l'incompatibilité cellulaire et l'incompatibilité sexuelle chez le Podospora anserina. Ann Sci Natl Bot 6: 611-768.
130. Dalstra HJ, Swart K, Debets AJ, Saupe SJ, Hoekstra RF. 2003. Sexual transmission of the [Het-s] prion leads to meiotic drive in Podospora anserina. Proc Natl Acad Sci U S A 100: 6616-6621. http://dx.doi.org/10.1073/pnas.1030058100.
131. Joseph SB, Kirkpatrick M. 2008. Effects of [PSI+] prion on rates of adaptation in yeast. J Evol Biol 21: 773-780. http://dx.doi.org/10.1111/j.1420-9101.2008.01515.x.
132. Namy O, Galopier A, Martini C, Matsufuji S, Fabret C, Rousset C. 2008. Epigenetic control of polyamines by the prion [PSI+]. Nat Cell Biol 10: 1069-1075. http://dx.doi.org/10.1038/ncb1766.
133. Tyedmers J, Madariaga ML, Lindquist S. 2008. Prion switching in response to environmental stress. PLoS Biol 6: E294. http://dx.doi.org/10.1371/journal.pbio.0060294.
134. Westergard L, True HL. 2014. Extracellular environment modulates the formation and propagation of particular amyloid structures. Mol Microbiol 92: 698-715. http://dx.doi.org/10.1111/mmi.12579.
135. Halfmann R, Jarosz DF, Jones SK, Chang A, Lancster AK, Lindquist S. 2012. Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 482: 363-368. http://dx.doi.org/10.1038/nature10875.
136. Halfmann R, Alberti S, Lindquist S. 2010. Prions, protein homeostasis, and phenotypic diversity. Trends Cell Biol 20: 125-133. http://dx.doi.org/10.1016/j.tcb.2009.12.003.
137. Benko AL, Vaduva G, Martin NC, Hopper AK. 2000. Competition between a sterol biosynthetic enzyme and tRNA modification in addition to changes in the protein synthesis machinery causes altered nonsense suppression. Proc Natl Acad Sci U S A 97: 61-66. http://dx.doi.org/10.1073/pnas.97.1.61.
138. Debets AJ, Dalstra HJ, Slakhorst M, Koopmanschap B, Hoekstra RF, Saupe SJ. 2012. High natural prevalence of a fungal prion. Proc Natl Acad Sci U S A 109: 10432-10437. http://dx.doi.org/10.1073/pnas.1205333109.
139. Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB. 2005. Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci U S A 102: 10575-10580. http://dx.doi.org/10.1073/pnas.0504882102.
140. Futcher AB, Cox BS. 1983. Maintenance of the 2 microns circle plasmid in populations of Saccharomyces cerevisiae. J Bacteriol 154: 612-622.
141. Futcher B, Reid E, Hickey DA. 1988. Maintenance of the 2 micron circle plasmid of Saccharomyces cerevisiae by sexual transmission: An example of selfish DNA. Genetics 118: 411-415.
142. Mead DJ, Gardner DCJ, Oliver SG. 1986. The yeast 2 μ plasmid: Strategies for the survival of a selfish DNA. Mol Gen Genet 205: 417-421. http://dx.doi.org/10.1007/BF00338076.
143. Kelly AC, Busby B, Wickner RB. 2014. Effect of domestication on the spread of the [PIN-] prion in Saccharomyces cerevisiae. Genetics 197: 1007-1024. http://dx.doi.org/10.1534/genetics.114.165670.
144. Kryndushkin D, Pripuzova N, Burnett B, Shewmaker F. 2013. Nontargeted identification of prions and amyloid-forming proteins from yeast and mammalian cells. J Biol Chem 288: 27100-27111. http://dx.doi.org/10.1074/jbc.M113.485359.
145. Taneja V, Maddelein ML, Talarek N, Saupe SJ, Liebman SW. 2007. A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol Cell 27: 67-77. http://dx.doi.org/10.1016/j.molcel.2007.05.027.
146. Reidy M, Sharma R, Masison DC. 2013. Schizosaccharomyces pombe disaggregation machinery chaperones support Saccharomyces cerevisiae growth and prion propagation. Eukaryot Cell 12: 739-745. http://dx.doi.org/10.1128/EC.00301-12.
147. Reidy M, Masison DC. 2012. Prokaryotic chaperones support yeast prions and thermotolerance and define disaggregation machinery interactions. Genetics 192: 185-193. http://dx.doi.org/10.1534/genetics.112.142307.
148. Afanasieva EG, Kushnirov VV, Tuite MF, Ter-Avanesyan MD. 2011. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast. J Biol Chem 286: 15773-15780. http://dx.doi.org/10.1074/jbc.M110.183889.
149. Nakayashiki T, Ebihara K, Bannai H, Nakamura Y. 2001. Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol Cell 7: 1121-1130. http://dx.doi.org/10.1016/S1097-2765(01)00259-3.
150. Harrison LB, Yu Z, Stajich J E, Dietrich FS, Harrison PM. 2007. Evolution of budding yeast prion-determinant sequences across diverse fungi. J Mol Biol 368: 273-282. http://dx.doi.org/10.1016/j.jmb.2007.01.070.
151. Edskes HE, Khamar HJ, Winchester C-L, Greenler AJ, Zhou A, McGlinchey RP, Gorkovskiy A, Wickner RB. 2014. Sporadic distribution of prion-forming ability of Sup35p from yeasts and fungi. Genetics 198: 605-616. http://dx.doi.org/10.1534/genetics.114.166538.
152. Safadi RA, Talarek N, Jacques N, Aigle M. 2011. Yeast prions: Could they be exaptations? The URE2/[URE3] system in Kluyveromyces lactis. FEMS Yeast Res 11: 151-153. http://dx.doi.org/10.1111/j.1567-1364.2010.00700.x.
153. Edskes HK, Engel A, McCann LM, Brachmann A, Tsai H-F, Wickner RB. 2011. Prion-forming ability of Ure2 of yeasts is not evolutionarily conserved. Genetics 188: 81-90. http://dx.doi.org/10.1534/genetics.111.127217.
154. Edskes HK, Wickner RB. 2013. The [URE3] prion in Candida. Eukaryot Cell 12: 551-558. http://dx.doi.org/10.1128/EC.00015-13.
155. Engel A, Shewmaker F, Edskes HK, Dyda F, Wickner RB. 2011. Amyloid of the Candida albicans Ure2p prion domain is infectious and has a parallel in-register β-sheet structure. Biochemistry 50: 5971-5978. http://dx.doi.org/10.1021/bi200142x.
156. Schwimmer C, Masison DC. 2002. Antagonistic interactions between yeast [PSI+] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p. Mol Cell Biol 22: 3590-3598. http://dx.doi.org/10.1128/MCB.22.11.3590-3598.2002.
157. Denic V, Dotsch V, Sinning I. 2013. Endoplasmic reticulum targeting and insertion of tail-Anchored membrane proteins by the GET pathway. Cold Spring Harb Perspect Biol 5: A013334. http://dx.doi.org/10.1101/cshperspect.a013334.
158. Escusa-Toret S, Vonk WIM, Frydman J. 2013. Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress. Nat Cell Biol 15: 1231-1243. http://dx.doi.org/10.1038/ncb2838.
159. Glover JR, Lindquist S. 1998. Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins. Cell 94: 73-82. http://dx.doi.org/10.1016/S0092-8674(00)81223-4.
160. Schlieker C, Tews I, Bukau B, Mogk A. 2004. Solubilization of aggregated proteins by ClpB/DnaK relies on the continuous extraction of un-folded polypeptides. FEBS Lett 578: 351-356. http://dx.doi.org/10.1016/j.febslet.2004.11.051.
161. Winkler J, Tyedmers J, Bukau B, Mogk A. 2012. Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. J Cell Biol 198: 387-404. http://dx.doi.org/10.1083/jcb.201201074.
162. Chernoff YO, Lindquist SL, Ono B-I, Inge-Vechtomov SG, Liebman SW. 1995. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880-884. http://dx.doi.org/10.1126/science.7754373.
163. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF. 2001. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40: 1357-1369. http://dx.doi.org/10.1046/j.1365-2958.2001.02478.x.
164. Jung G, Jones G, Masison DC. 2002. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci U S A 99: 9936-9941. http://dx.doi.org/10.1073/pnas.152333299.
165. Jung G, Masison DC. 2001. Guanidine hydrochloride inhibits Hsp104 activity in vivo: A possible explanation for its effect in curing yeast prions. Curr Microbiol 43: 7-10. http://dx.doi.org/10.1007/s002840010251.
166. Cox BS, Ness F, Tuite MF. 2003. Analysis of the generation and segregation of propagons: Entities that propagate the [PSI+] prion in yeast. Genetics 165: 23-33.
167. Eaglestone SS, Ruddock LW, Cox BS, Tuite MF. 2000. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI+] of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 97: 240-244. http://dx.doi.org/10.1073/pnas.97.1.240.
168. Ness F, Ferreira P, Cox BS, Tuite MF. 2002. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22: 5593-5605. http://dx.doi.org/10.1128/MCB.22.15.5593-5605.2002.
169. Jung G, Jones G, Wegrzyn RD, Masison DC. 2000. A role for cytosolic Hsp70 in yeast [PSI(+)] prion propagation and [PSI(+)] as a cellular stress. Genetics 156: 559-570.
170. Roberts BT, Moriyama H, Wickner RB. 2004. [URE3] prion propagation is abolished by a mutation of the primary cytosolic Hsp70 of budding yeast. Yeast 21: 107-117. http://dx.doi.org/10.1002/yea.1062.
171. Sharma D, Masison DC. 2008. Functionally redundant isoforms of a yeast Hsp70 chaperone subfamily have different antiprion effects. Genetics 179: 1301-1311. http://dx.doi.org/10.1534/genetics.108.089458.
172. Sharma D, Masison DC. 2011. Single methyl group determines prion propagation and protein degradation activities of yeast heat shock protein Hsp)-70 chaperones Ssa1p and Ssa2p. Proc Natl Acad Sci U S A 108: 13665-13670. http://dx.doi.org/10.1073/pnas.1107421108.
173. Jones G, Song Y, Chung S, Masison DC. 2004. Propagation of yeast [PSI+] prion impaired by factors that regulate Hsp70 substrate binding. Mol Cell Biol 24: 3928-3937. http://dx.doi.org/10.1128/MCB.24.9.3928-3937.2004.
174. Kryndushkin D, Wickner RB. 2007. Nucleotide exchange factors for Hsp70s are required for [URE3] prion propagation in Saccharomyces cerevisiae. Mol Biol Cell 18: 2149-2154. http://dx.doi.org/10.1091/mbc.E07-02-0128.
175. Fan Q, Park K-W, Du Z, Morano KA, Li L. 2007. The role of Sse1 in the de novo formation and variant determination of the [PSI+] prion. Genetics 177: 1583-1593. http://dx.doi.org/10.1534/genetics.107.077982.
176. Higurashi T, Hines JK, Sahi C, Aron R, Craig EA. 2008. Specificity of the J-protein Sis1 in the propagation of 3 yeast prions. Proc Natl Acad Sci U S A 105: 16596-16601. http://dx.doi.org/10.1073/pnas.0808934105.
177. Kirkland PA, Reidy M, Masison DC. 2011. Functions of yeast Hsp40 chaperone Sis1p dispensable for prion propagation but important for prion curing and protection from prion toxicity. Genetics 188: 565-577. http://dx.doi.org/10.1534/genetics.111.129460.
178. Hines JK, Li X, Du Z, Higurashi T, Li L, Craig EA. 2011. [SWI], the prion formed by the chromatin remodeling factor Swi1, is highly sensitive to alterations in Hsp70 chaperone system activity. PLoS Genet 7: E1001309. http://dx.doi.org/10.1371/journal.pgen.1001309.
179. Reidy M, Masison DC. 2011. Modulation and elimination of yeast prions by protein chaperones and co-chaperones. Prion 5: 245-249. http://dx.doi.org/10.4161/pri.17749.
180. Moosavi B, Wongwigkam J, Tuite MF. 2010. Hsp70/Hsp90 cochaperones are required for efficient Hsp104-mediated elimination of the yeast [PSI+] prion but not for prion propagation. Yeast 27: 167-179. http://dx.doi.org/10.1002/yea.1742.
181. Reidy M, Masison DC. 2010. Sti1 regulation of Hsp70 and Hsp90 is critical for curing of Saccharomyces cerevisiae [PSI+] prions by Hsp104. Mol Cell Biol 30: 3542-3552. http://dx.doi.org/10.1128/MCB.01292-09.
182. Hung GC, Masison DC. 2006. N-Terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression. Genetics 173: 611-620. http://dx.doi.org/10.1534/genetics.106.056820.
183. Helsen CW, Glover JR. 2012. Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein Hsp104). J Biol Chem 287: 542-556. http://dx.doi.org/10.1074/jbc.M111.302869.
184. Chernoff YO, Newnam GP, Kumar J, Allen K, Zink AD. 1999. Evidence for a protein mutator in yeast: Role of the Hsp70-related chaperone Ssb in formation, stability and toxicity of the [PSI+] prion. Mol Cell Biol 19: 8103-8112.
185. Allen KD, Wegrzyn RD, Chernova TA, Muller S, Newnam GP, Winslett PA, Wittich KB, Wilkinson KD, Chernoff YO. 2005. Hsp70 chaperones as modulators of prion life cycle: Novel effects of Ssa and Ssb on the Saccharomyces cerevisiae prion [PSI+]. Genetics 169: 1227-1242. http://dx.doi.org/10.1534/genetics.104.037168.
186. Kiktev DA, Patterson JC, Muller S, Bariar B, Pan T, Chernoff YO. 2012. Regulation of the chaperone effects on a yeast prion by the cochaperone Sgt2. Mol Cell Biol 32: 4960-4970. http://dx.doi.org/10.1128/MCB.00875-12.
187. Kryndushkin D, Shewmaker F, Wickner RB. 2008. Curing of the [URE3] prion by Btn2p, a Batten disease-related protein. EMBO J 27: 2725-2735. http://dx.doi.org/10.1038/emboj.2008.198.
188. Kanneganti V, Kama R, Gerst JE. 2011. Btn3 is a negative regulator of Btn2-mediated endosomal protein trafficking and prion curing in yeast. Mol Biol Cell 22: 1648-1663. http://dx.doi.org/10.1091/mbc.E10-11-0878.
189. Kaganovich D, Kopito R, Frydman J. 2008. Misfolded proteins partition between two distinct quality control compartments. Nature 454: 1088-1095. http://dx.doi.org/10.1038/nature07195.
190. Specht S, Miller SBM, Mogk A, Bukau B. 2011. Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol 195: 617-629. http://dx.doi.org/10.1083/jcb.201106037.
191. Malinovska L, Kroschwald S, Munder MC, Richter D, Alberti S. 2012. Molecular chaperones and stress-inducible protein-sorting factors coordinate the spaciotemporal distribution of protein aggregates. Mol Biol Cell 23: 3041-3056. http://dx.doi.org/10.1091/mbc.E12-03-0194.
192. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman JS. 2003. Global analysis of protein expression in yeast. Nature 425: 737-741. http://dx.doi.org/10.1038/nature02046.
193. Kryndushkin D, Ihrke G, Piermartiri TC, Shewmaker F. 2012. A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Mol Microbiol 86: 1531-1547. http://dx.doi.org/10.1111/mmi.12075.
194. Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, Costello CE, Sherman MY. 2009. Abnormal proteins can form aggresome in yeast: Aggresome-Targeting signals and components of the machinery. FASEB J 23: 451-463. http://dx.doi.org/10.1096/fj.08-117614.
195. Kopito R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530. http://dx.doi.org/10.1016/S0962-8924(00)01852-3.
196. Pearce DA, Ferea T, Nosel SA, Das B, Sherman F. 1999. Action of BTN1, the yeast ortholog of the gene mutated in Batten disease. Nat Genet 22: 55-58. http://dx.doi.org/10.1038/8861.
197. Kama R, Robinson M, Gerst JE. 2007. Btn2, a Hook1 ortholog and potential Batten disease-related protein, mediates late endosome-Golgi protein sorting in yeast. Mol Cell Biol 27: 605-621. http://dx.doi.org/10.1128/MCB.00699-06.
198. Szebenyi G, Wigley WC, Hall B, Didier A, Yu M, Thomas P, Kramer H. 2007. Hook2 contributes to aggresome formation. BMC Cell Biol 8: 19. http://dx.doi.org/10.1186/1471-2121-8-19.
199. Cascarina SM, Ross ED. 2014. Yeast prions and human prion-like proteins: Sequence features and prediction methods. Cell Mol Life Sci 71: 2047-2063. http://dx.doi.org/10.1007/s00018-013-1543-6.
200. Zhang B, Une Y, Fu X, Yan J, Ge F, Yao J, Sawashita J, Mori M, Tomozawa H, Kametani F, Higuchi K. 2008. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci U S A 105: 7263-7268. http://dx.doi.org/10.1073/pnas.0800367105.
201. Qian J, Yan J, Ge F, Zhang B, Fu X, Tomozawa H, Sawashita J, Mori M, Higuchi K. 2010. Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity. PLoS Pathol 6: E1000914. http://dx.doi.org/10.1371/journal.ppat.1000914.
202. Krammer C, Kryndushkin D, Suhre MH, Kremmer E, Hofmann A, Pfeifer A, Scheibel T, Wickner RB, Schatzl HM, Vorberg I. 2009. The yeast Sup35NM domain propagates as a prion in mammalian cells. Proc Natl Acad Sci U S A 106: 462-467. http://dx.doi.org/10.1073/pnas.0811571106.
203. Hofmann JP, Denner P, Nussbaum-Krammer C, Kuhn P-H, Suhre MH, Scheibel T, Lichtenthaler SF, Schatzl HM, Bano D, Vorberg IM. 2013. Cell-To-cell propagation of infectious cytosolic protein aggregates. Proc Natl Acad Sci USA110: 5951-5956. http://dx.doi.org/10.1073/pnas.1217321110.
204. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R. 2013. Molecular structure of β-Amyloid fibrils in Alzheimer's disease brain tissue. Cell 154: 1257-1268. http://dx.doi.org/10.1016/j.cell.2013.08.035.
205. Nguyen P, Oumata M, Soubigou F, Evrard J, Desban N, Lemoine P, Bouaziz S, Blondel M, Voisset C. 2014. Evaluation of the antiprion activity of 6-Aminophenanthridines and related heterocycles. Eur J Med Chem 82C: 363-371. http://dx.doi.org/10.1016/j.ejmech.2014.05.083.
206. Bharadwaj P, Martins R, Macreadie I. 2010. Yeast as a model for studying Alzheimer's disease. FEMS Yeast 10: 961-969. http://dx.doi.org/10.1111/j.1567-1364.2010.00658.x.
207. Braun RJ, Buttner S, Ring J, Kroemer G, Madeo F. 2010. Nervous yeast: Modeling neurotoxic cell death. Trends Biochem Sci 35: 135-144. http://dx.doi.org/10.1016/j.tibs.2009.10.005.
208. Khurana V, Lindquist S. 2010. Modelling neurodegeneration in Saccharomyces cerevisiae: Why cook with baker's yeast? Nat Rev Neurosci 10: 436-449. http://dx.doi.org/10.1038/nrn2809.
209. Winderickx J, Delay C, De Vox A, Klinger H, Pellens K, Vanhelmont T, van Leuven F, Zabrocki P. 2008. Protein folding diseases and neurodegeneration: Lessons learned from yeast. Biochim Biophys Acta 1783: 1381-1395. http://dx.doi.org/10.1016/j.bbamcr.2008.01.020.
210. Chesebro B. 1997. Human TSE disease-viral or protein only? Nat Med 3: 491-492. http://dx.doi.org/10.1038/nm0597-491.
211. Weissmann C, Bueler H, Sailer A, Fischer M, Aguet M, Aguzzi A. 1993. Role of PrP in prion diseases. Br Med Bull 49: 995-1011.
212. Cobb NJ, Sonnichsen FD, Mchaourab H, Surewicz WK. 2007. Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure. Proc Natl Acad Sci U S A 104: 18946-18951. http://dx.doi.org/10.1073/pnas.0706522104.
213. Groveman BR, Dolan MA, Taubner LM, Kraus A, Wickner RB, Caughey B. 2014. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein PrP. amyloids. J Biol Chem 289: 24129-24142. http://dx.doi.org/10.1074/jbc.M114.578344.
214. Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV. 2010. The-helical C-Terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: Evidence from solid state nuclear magnetic resonance. Biochemistry 49: 9488-9497. http://dx.doi.org/10.1021/bi1013134.
215. Petkova AT, Yau WM, Tycko R. 2006. Experimental constraints on quaternary structure in Alzheimer's beta-Amyloid fibrils. Biochemistry 45: 498-512. http://dx.doi.org/10.1021/bi051952q.
216. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T. 2007. Prions of fungi: Inherited structures and biological roles. Nat Rev Microbiol 5: 611-618. http://dx.doi.org/10.1038/nrmicro1708.
217. Masison DC, Kirkland PA, Sharma D. 2009. Influence of Hsp70s and their regulators on yeast prion propagation. Prion 3: 65-73. http://dx.doi.org/10.4161/pri.3.2.9134.